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Periodontal disease is associated with cardiovascular disease
and is thought to accelerate systemic atherosclerosis. Here
we examined the relationship between periodontitis and
cardiovascular disease mortality in outpatients on
hemodialysis using a retrospective analysis of 168 adult
patients in New York City and North Carolina. During 18
months of follow-up, cardiovascular disease and all-cause
mortality were determined from a centralized dialysis
registry. One hundred patients had mild or no periodontal
disease but the remaining 68 had moderate-to-severe
disease defined as 2 or more teeth with at least 6 mm of
inter-proximal attachment loss. At baseline, the proportion of
males was significantly lower in the moderate-to-severe
group. Compared with mild or no periodontal disease,
moderate-to-severe disease was significantly associated with
death from cardiovascular causes. Adjustment for age,
gender, center and dialysis vintage, smoking status, and
history of diabetes mellitus or hypertension did not diminish
the strength of this association. Our findings suggest a need
for larger studies to confirm this connection, along with
intervention trials to determine if treating periodontitis
reduces cardiovascular disease mortality in dialysis patients.
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Atherosclerosis is thought to be an inflammatory disease.1
Chronic periodontitis, caused by subgingival infection with
predominantly gram negative anaerobic bacteria in disease
susceptible individuals, can contribute to systemic inflam-
mation (Figure 1).2–4 Periodontal pathogens are capable of
invading the systemic circulation and of stimulating an
hepatic acute phase response.5,6 In addition, some period-
ontal pathogens are capable of invading the endothelium of
major elastic arteries7 and atheromatous plaques.8,9
Most epidemiological studies have found periodontitis to
be associated with cardiovascular disease (CVD), even after
adjustment for a variety of medical and socioeconomic
confounders.2–4 Intervention studies have shown that the
treatment of periodontal disease improves serum inflamma-
tory markers10,11 and flow-mediated arterial dilation,12–16 a
marker of endothelial function that becomes dysfunctional
early in the course of atherosclerosis.
Recent evidence suggests a high prevalence of period-
ontitis in individuals with early stages of chronic kidney
disease (CKD)17–19 as well as in those with end-stage kidney
disease.20,21 We postulated that the presence of periodontal
disease may adversely affect CVD mortality in a population
with a high burden of CVD, namely patients with CKD. We
examined the relationship between periodontitis and CVD
mortality in a cohort of patients receiving chronic outpatient
hemodialysis.
RESULTS
At the 4 dialysis units, a total of 523 patients were potentially
eligible for the study and were evaluated for participation by
two study examiners (AK and MY), Figure 2. Several patients
refused participation (n¼ 199), whereas others could not
participate because of a lack of teeth (n¼ 156). A total of 168
subjects had dental examinations for the evaluation of
periodontal disease; 106 at the units in New York City and
62 at the units in North Carolina. A total of 100 subjects had
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mild or no periodontal disease, and 68 had moderate-to-
severe disease (Table 1).
At baseline, the two groups differed only with respect to
the proportion of females. Notably, there was no difference in
measured baseline CVD risk factors, including prevalent
hypertension, prevalent diabetes mellitus, smoking status,
and blood pressure. There were also no differences in the
cause of end-stage renal disease (ESRD), type of dialysis
access, dialysis adequacy, dialysis vintage, and measures of
renal osteodystrophy between the two groups. Finally, average
values of serum albumin were comparable between the two
groups; both groups had elevated levels of CRP that were not
significantly different.
During the 18-month follow-up period, there were 22
deaths; 14 of the deaths were from CVD, while 8 were from
other causes (Table 2). Survival by periodontal status is
displayed in Figure 3 as a Kaplan–Meier survival plot.
Moderate-to-severe periodontitis was significantly associated
with CVD mortality compared with mild or none period-
ontitis, hazards ratio (95% confidence interval) 5.3
(1.5–18.9), P¼ 0.01; Table 3. Subsequent adjustment for a
variety of co-variables, including age, sex, center, dialysis
vintage, smoking, diabetes mellitus, and hypertension, did
not significantly alter the strength of association, HR 5.0
(95% confidence interval, 1.2-19.1; P¼ 0.02).
Moderate-to-severe periodontitis was not significantly
associated with all cause mortality, hazards ratio (95%
confidence interval) 1.8 (0.7–4.5) compared with mild or
none periodontitis.
DISCUSSION
In this retrospective cohort study, we observed that
moderate-to-severe periodontal disease was strongly asso-
ciated with CVD mortality. Patients with severe-to-moderate
periodontal disease had a 5-fold increase in CVD death after
18 months of follow-up. Adjustment for available demo-
graphic and medical characteristics did not eliminate the
association. We did not observe an association of moderate-
to-severe periodontal disease with all-cause mortality,
possibly suggesting a degree of specificity to CVD morbidity.
Complications from coronary heart disease and cerebro-
vascular disease remain the leading causes of mortality and
morbidity in the ESRD population.22 Conventional, Fra-
mingham-type risk factors for atherosclerosis may only
account for 50 to 70% of atherosclerotic events.23 Non-
conventional risk factors for accelerated atherosclerosis in
CKD include anemia, high pulse pressure, disordered mineral
and vitamin D metabolism, and hyperhomocystinemia, and
possibly, increased oxidative stress.24,25 Inflammation is
closely linked to increased oxidative stress.
Biofilms in the oral cavity contain greater than 1010
organisms3 many of which are pathogenetic for periodontitis.
Monocytes and dendritic cells within local periodontal tissues
recognize bacterial cell wall lipopolysaccharides and other
toll-like receptor-agonists. These cells secrete various inflam-
matory mediators, including prostaglandin E2, interleukin-
1b, interleukin-6, and tumor necrosis factor-a.2,5 Gingival
pathogens, also capable of invading the systemic circulation,
can affect the host through one of two inter-related
mechanisms. First, these organisms promote hepatic activa-
tion and release of acute phase reactants, such as interleukin-
6 and CRP.5,6 High circulating levels of CRP may then
activate complement.26 Furthermore, CRP has also been
demonstrated to cause calcium dependent binding and
aggregation of LDL and very LDL cholesterol.27
Second, the organisms, especially P. gingivalis, can invade
the human endothelial cells (see Despande et al.,7 Dorn
et al.8) endothelial lining and atheromatous plaques.9 It is
highly likely that these organisms can alter endothelial
function, platelet function, and plaque stability. A recent
study demonstrated that infection of human aortic endothe-
lial cells with P. gingivalis promoted adhesion of monocytes
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Figure 1 | Periodontal disease and destruction. Periodontal
tissues and disease destruction. (a) Diagram depicts a tooth with
the periodontal tissues (cementum, connective tissue, and
alveolar bone) being healthy on the left side and compromised
due to periodontal disease on the right side of the tooth. Tissues
are labeled and arrows point to the corresponding areas. (b)
Radiograph of molar teeth. Local destruction of supporting
alveolar bone due to periodontal disease is demonstrated by the
right arrow, while bone levels are shown to be optimal by the left
arrow. (From Reference 4, all permissions granted from the New
York Academy of Sciences)
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Figure 2 | Flow diagram of patient enrollment into cohort.
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and T-cells.28 Another related study showed that infection of
human aortic endothelial cells promoted coagulation by
raising levels of tissue factor and lowering levels of tissue
plasminogen activator.29 Finally, a study of subjects with
severe periodontitis showed increased platelet activation
compared with healthy controls.30 Speculatively, the net
effect of systemic invasion by these organisms would be to
adversely affect endothelial function,31–33 and thrombosis,
important precursors of clinical CVD.
Epidemiological studies have confirmed an association
between periodontitis and CVD.2–4 A recent meta-analysis of
all available type of association studies—prospective cohort
studies, case–control studies, and cross-sectional studies,
consistently demonstrated a direct association of periodontal
disease and coronary heart disease.34 Intervention studies
have demonstrated a reduction in the systemic levels of CRP,
interleukin-6, and LDL-cholesterol following periodontal
therapy.10,11 Several independent intervention trials have
Table 1 | Baseline demographic and medical characteristics by periodontal disease status (mean and standard deviation for
continuous variables and frequency for categorical variables)
Variable None/mild periodontitis N=100 Moderate/severe periodontitis N=68 P value
Age, years 52.2 (13.0) 55.7 (13.3) 0.23
Sex male 54% 34% 0.01
Race (non-Hispanic white) 15% 9% 0.23
Cause of ESRD 0.63
Hypertension 57% 50%
Diabetes mellitus 19% 27%
Glomerulonephritis 8% 7%
Polycystic kidney disease 1% 3%
Othera 15% 13%
Dialysis vintage, years 3.8 (2.7) 4.0 (3.8) 0.67
Hypertension 84% 91% 0.18
Body mass index 28.3 (6.7) 28.9 (8.6) 0.62
Current smoker 79% 66% 0.07
High school education or lowerb 61% 59% 0.74
Systolic blood pressure, mm Hg 153 (2.2) 152 (2.9) 0.80
Diastolic blood pressure, mm Hg 82 (1.3) 83 (1.6) 0.75
Vascular access 0.31
Fistula 24% 65%
Graft 23% 18%
Catheter 53% 17%
Serum albumin, mg/100 ml 3.9 (0.4) 3.9 (0.4) 0.61
C-reactive protein, mg/l 8.5 (17.8) 6.5 (11.2) 0.23
Serum calcium, mg/100 ml 9.2 (0.9) 9.3 (0.7) 0.52
Serum phosphorus, mg/100 ml 5.8 (1.7) 5.8 (1.6) 0.76
Serum PTH, pg/ml 363 (355) 450 (344) 0.21
Serum total cholesterol, mg/100 ml 148 (35) 144 (35) 0.57
Dialysis adequacy (ekDrT/V) 1.39 (0.04) 1.44 (0.04) 0.32
Serum ferritin, mg/l 432 (345) 410 (278) 0.15
ESRD, end-stage renal disease.
aOther includes unknown, failed kidney transplant, obstruction, congenital abnormalities, acute kidney injury without recovery.
bAvailable only for patients from New York City dialysis clinics.
Table 2 | Causes of death for study subjects
Cause of death
Cardiovascular disease Other
Cardiac arrest 10 Sepsis 2
Cerebrovascular accident
(hemorrhagic)
2 Respiratory failure 1
Cardiomyopathy 1 Cachexia 1
Pericarditis 1 Accident 1
Hemolytic uremia syndrome 1
Tuberculosis 1
Unknown 1
Totals 14 8
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Figure 3 | Kaplan–Meier survival curve (P¼ 0.01).
Perio, periodontal disease.
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demonstrated improved flow-mediated dilation following
periodontal therapy for up to 6 months after therapy.12–16
Our study has important limitations, most reflecting the
nature of a retrospective cohort analysis. First, and foremost,
we did not have baseline measurements of the burden of
CVD. Thus, the observed findings may have been con-
founded by the presence of variable degrees of occult CVD.
Alternatively stated, if periodontitis is predictive of future
CVD events, it follows that it would also be associated with
baseline CVD. It is important to note that in our study risk
factors for baseline CVD, total cholesterol, age, smoking,
diabetes mellitus, and hypertension did not vary significantly
between the two groups. Yet, we cannot exclude the
possibility of residual confounding from variables that were
not explicitly measured or from those that were differentially
associated with the currently measured variables.
Second, we did not have complete information on
socioeconomic status or nutrition. It has been proposed that
the observed association between periodontal disease and
CVD is confounded by SES, diet, and access to dental care.
Yet, the general dialysis population in the United States is
generally homogenous with respect to income, disability, and
insurance status.
Third, our sample size was modest. Thus, even though the
magnitude of the hazards ratio is large with regard to
potential clinical impact, the confidence intervals are wide.
Furthermore, the small number of incident events limits the
potential adjustment variables, and in fact, over-adjustment
remains a distinct possibility in our models.
Fourth, we could not confirm the cause of death for
patients. The majority of deaths were reported to be from
cardiac arrest. Although it seems reasonable to assume that
the sentinel event prior to cardiac arrest was an ischemic
coronary event and/or arrhythmia, it remains an assumption.
Finally, the small number of deaths, both all-cause and
cardiovascular, suggest that the observed population may
have been healthier than the average patient receiving
hemodialysis. Over 50% of available patients were not
included in the study for either edentulousness or refusal
to participate. It is unclear whether this affected the validity
of the observed association, but it may affect generalizability
to the overall ESRD population. In future studies, it will be
important to examine baseline characteristics of edentuluous
patients or those declining participation.
Paradoxically, the two groups of patients did not vary with
respect to the average values of CRP and serum albumin at
baseline. For CRP, others have demonstrated a similar lack of
association of CRP with periodontal disease in the ESRD
population.20,21 In a group of patients with Stages 3 and 4
CKD, furthermore, we also observed that there was no
association of periodontal disease and CRP.18 A potential
explanation for serum albumin is less forthcoming. It may
relate to the severity of periodontal disease captured by the
current definition of periodontitis; that is, serum albumin
does not decrease until there is greater severity of periodontal
disease. Alternatively, the lack of association suggests
investigation of other potential mechanisms to explain the
observed periodontitis and CVD mortality relationship, such
as direct invasion of the vasculature and/or destabilization of
the endothelium and atheromas by periodontal organisms.
At the very least, the findings of this preliminary study need
replication.
In this preliminary study, moderate-to-severe periodontal
disease was strongly associated with CVD mortality in a
cohort of dialysis patients. Given the high burden of
unexplained CVD among ESRD patients and among the
larger CKD population (in excess of 18 million), investigation
of mutable new risk factors appears to be a logical next step.
Future studies should examine whether the treatment of
periodontitis could improve CVD morbidity and mortality
among individuals at various stages of CKD, including those
receiving hemodialysis.
MATERIALS AND METHODS
Between January 2001 and December 2005, patients were enrolled in
a study to determine the prevalence of periodontal disease in the
end-stage kidney disease population. The study was based at two
separate sites in a total of 4 dialysis units, 2 in central North
Carolina and 2 in New York City. To be eligible for the study,
patients had to be older than 18 years, have a dialysis vintage of at
least 3 months, be English speaking, and have at least one natural
tooth. Two study authors (AVK and MY) approached patients
consecutively and obtained informed consent. Six dental examiners,
all trained and calibrated at the University of North Carolina at
Chapel Hill (under the guidance of study author JDB), performed
the periodontal evaluation. Four of the dental examiners performed
the periodontal evaluation in North Carolina, whereas 2 did so in
the New York City. The protocol was approved by the Committees
on Research Involving Human Subjects at UNC School of Medicine
and the New York University School of Medicine Institutional Board
of Research Associates.
During the hemodialysis session, trained and calibrated exam-
iners evaluated six sites per tooth (up to 32 teeth per patient).
Standard measures of periodontal health were recorded including
gingival recession (the linear distance in millimeters between the
gingival margin and the cementoenamel junction), and probing
depth (the linear distance in millimeters from the gingival margin to
the base of the periodontal pocket). Attachment level, a measure of
destructive periodontitis, was calculated as probing depth minus the
cementoenamel junction measurement.
Table 3 | Hazard ratio (95% confidence interval) for death
from CVD by periodontal disease status model with the
none/mild group as the referent
None/mild
periodontitis
Moderate/severe
periodontitis P value
Model 1 1.00 5.3 (1.5–18.9) 0.01
Model 2 1.00 5.7 (1.5–21.2) 0.009
Model 3 1.00 5.0 (1.2–19.1) 0.02
Model 1: Univariate.
Model 2: Model 1 and age, center, sex.
Model 3: Model 2 and dialysis vintage, smoking status, cause of end-stage renal
disease (ESRD) diabetes mellitus, cause of ESRD hypertension.
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Periodontal disease was defined by the presence of significant
attachment (level) loss and pocket depth. Moderate-to-severe
periodontitis was defined as 2 or more teeth with at least 6 mm
interproximal attachment level and at least 1 site with probing depth
45 mm. Mild or no periodontitis was defined by the absence of
these findings.
Demographic and medical information was abstracted from
patient charts as well as by direct interview by two of the study
authors (AVK and MY). Neither interviewer/data abstractor was
aware of the periodontal disease status of the participants at the time
of data abstraction. Age was determined in years at the date of the
examination. Gender, race, and smoking status (current, former,
never) were determined by self-report at the time of dental
evaluation. Information on duration of dialysis and cause of end-
stage kidney disease was obtained from the Medicare 2720 form.
Laboratory information was obtained from a central laboratory,
SPECTRA, for serum measurements: albumin, calcium, phos-
phorus, parathyroid hormone, cholesterol, ferritin, and dialysis
adequacy (equilibrated Kt/V). Information on dialysis access (graft,
fistula, or catheter) was obtained from a computerized central
registry of patient information at Renal Research Institute. Serum C-
reactive protein was determined by a high sensitivity assay of blood
drawn from participants on the day of the evaluation. It was not
available in the SPECTRA laboratory system.
Information on death was obtained from a centralized computer
database of patients at dialysis centers managed by Renal Research
Institute. The cause of death was determined by physicians rounding
at the different dialysis centers, and then entered into a centralized,
computerized dialysis registry by the nurse manager at each unit.
The unique study identification number was used to link the
participating patient with the registry data.
Statistical analysis
We first compared patient characteristics by periodontal disease
using t-tests for continuous variables and Chi-squared tests for
categorical variables. CVD death was defined as death ascribed to
coronary heart disease (cardiac arrest), pericardial disease, cardio-
myopathy, and cerebrovascular disease (including thrombotic and
hemorrhagic cerebrovascular events).
Observed survival time was assessed starting from the
time of subject enrollment (clinical periodontal examination).
Follow-up time was ascertained on all patients up to 18 months
after determination of periodontal disease status. Kaplan–Meier
survival analysis was used to determine CVD mortality,
cardiac mortality, and all-cause mortality at 18 months. Cox
proportional hazards ratios were used to determine the risk of death
over time after adjusting for important demographic and medical
characteristics. The threshold for statistical significance was set at a P
value of less than 0.05. All analyses were performed using SAS,
version 9.2.
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